23andMe Investor Presentation Deck slide image

23andMe Investor Presentation Deck

(in $M) Revenue Cost of Revenue Gross Profit R&D S&M G&A Total Operating Expenses Income Statement and FY2022 Guidance Loss from Operations Interest and Other (Expense) Income Loss before Benefit for Income Taxes Benefit for Income Taxes Net Loss Note: Fiscal year ends March 31. Nine Months Ended December 31, FY2022 Amount $171 85 86 139 71 61 271 (185) 33 (152) 4 ($148) FY2021 Amount $155 83 72 114 31 46 191 (119) 2 (117) ($117) Year Ended March 31, FY2022 Guidance Amount $268 - $278 N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A ($220) - ($205) FY2021 Amount $244 127 117 160 43 99 302 H (185) 1 (184) ($184)
View entire presentation